Schedule 13D ownership disclosure
REPLICEL LIFE SCIENCES INC.
Security class unavailable · CUSIP: 76027P400
Event date: 2022-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,864,037
- Percent of class
- 16.4100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085037-23-000002
- Form type
- SC 13D
- Filer
- MACKAY JAMIE MYLES
- CIK
- CIK 1948302
- Filed
- Jan 05, 2023
- Reporting period
- Dec 30, 2022
- Description
- Schedule 13D beneficial ownership